The DZNE Rhineland Study is an ongoing, large-scale population-based cohort designed to investigate determinants of healthy aging and the development of neurodegenerative diseases across the lifespan.
These findings support the advancement of SUL-238 into further clinical development for Alzheimer's and other neurodegenerative diseases ...GEN licenses SUL-238 from Sulfateq BV for neurodegenerative disease applications.
The alpha-synuclein inhibitors market is driven by the growing prevalence of neurodegenerative disorders such as Parkinson's disease, Lewy body dementia, and multiple system atrophy, where alpha-synuclein aggregation plays a critical pathogenic role.
NEURODEGENERATIVE DISEASES AND TRAUMATIC BRAIN INJURY TABLE OF CONTENTS ... The purpose of this information paper is to summarize the available evidence on the association of TBI with three common neurodegenerative diseases.
Bacopa monnieri, an adaptogenic herb, contains powerful compounds like bacosides and quercetin that promote cognitive function, improve memory and... .
... pure neuronal cell populations which will help expand our understanding of cell types and cell interactions implicated in neurodegenerative diseases like Alzheimer’s, Parkinson's, and ALS.